Follow the 司太立 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 司太立 has published 9 insider filings. Market capitalisation: €4bn. The latest transaction was filed on 12 August 2026 (Purchase). Among the most active insiders: 胡锦生. Every trade is openly available.
9
Insider Decl.
n/a
Thresholds
€7m
3 ops.
Buy Volume
€5m
6 ops.
Sell Volume
22Σ signal
Buys €7m€5m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,656 of 29,064 companies
23.8
score / 100
Value
25
Quality
23
FCF yld-6.8%
Earn yld0.3%
EV/EBITDA20.8x
ROE0.6%
Gross mgn21%
Net mgn0.4%
Debt/EBITDA8.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.